DAVIS, Calif., March 23, 2020 /PRNewswire/ -- Arcadia
Biosciences, Inc. (Nasdaq: RKDA), a leader in science-based
approaches to enhancing the quality and nutritional value of crops
and food ingredients, today announced a new partnership between
Archipelago Ventures and Vivion Specialties, Inc. (VSI), a North
American specialty ingredient supplier. VSI will serve as
Archipelago's North American distributor, managing the stateside
marketing and sales of sun-grown Hawaiian hemp ingredients in key
markets like food and beverage, human and pet nutrition and
personal care.
Established in 2019, Archipelago Ventures is Arcadia's joint venture with Legacy Ventures
Hawaii to cultivate and extract high quality hemp and hemp
derivatives on the islands. The new partnership between Archipelago
and VSI is based on the companies' mutual goals of providing
ethically cultivated, genetically superior hemp-based ingredients
that have been rigorously tested for purity, offering customers
transparency and peace of mind. VSI is known for its proprietary
VivAssure® purity validation process, which tests every
ingredient and provides a detailed Certificate of Analysis of their
contents.
"When it comes to hemp and hemp-derived products like
cannabidiol (CBD), ingredient transparency and quality control are
a high priority for discerning retailers and shoppers," said
Arcadia CEO Matthew Plavan. "With
VivAssure, Vivion Specialties has pioneered a new and rigorous
standard for the testing and certification of hemp ingredients.
What's more, Vivion is an experienced specialty ingredient supplier
with a network of 18 sales regions in the U.S. and Canada, making them an ideal partner to
distribute what we expect will be the first Hawaiian-grown,
Hawaiian-extracted CBD ingredients available in North America," he added.
Archipelago's Hawaiian hemp products will be marketed as meeting
VivAssure product quality standards, validating that they are free
of over 950 pesticides and contaminants, 24 heavy metals and a
variety of microbial organisms, and contain the precise
tetrahydrocannabinol (THC) content and CBD profile listed.
"For more than sixty years, Vivion, Inc. has prioritized
providing customers with the highest quality product ingredients
across the food and beverage, human and pet nutrition and personal
care markets," said VSI CEO and Founder and Vivion, Inc. President
Michael Poleselli. "Through our
partnership with Archipelago and Arcadia Biosciences, a leader in
hemp innovation, we're applying these capabilities to one of the
most exciting and in-demand new consumer product categories:
hemp-derived CBD."
Archipelago and VSI's VivAssure Hemp-based ingredients are expected to be available for sale to
North American food, beverage, pet and supplement manufacturers
later this year.
About Archipelago Ventures, LLC
Established in 2019,
Archipelago Ventures is a joint venture between Arcadia
Biosciences, Inc. and Legacy Ventures Hawaii to cultivate and
extract high quality hemp and hemp derivatives on the islands. The
partnership joins Arcadia's
extensive genetic expertise and resources with Legacy's proven
experience in extraction and sales – and leverages Arcadia's existing licensed cultivation
facility in Hawaii, resulting in
one vertically integrated supply chain, from seed to sale. Former
Gold Glove and World Champion Major League Baseball
player Shane Victorino is a principal in the company, along
with other native islanders committed to building Hawaii's capacity to supply branded health and
wellness goods.
About Vivion Specialties, Inc.
Vivion Specialties,
Inc. (VSI) was founded in 2019 by Michael
Poleselli, President of Vivion, Inc. (VI). VSI and Vivion
Inc. (VI) have a combination of over 62 years of industry
experience specializing in ingredient distribution. VSI, Vivion
Specialties Canada, ULC and Vivion, Inc. currently have sales teams
in over 18 regions throughout British
Columbia and the United
States. Together, VSI and VI own the VivAssure®
brand and the proprietary VivAssure® testing
process, which rigorously screens product ingredients for more than
950 pesticides and contaminants, 24 heavy metals and a variety of
microbial organisms, providing a detailed Certificate of Analysis.
For more information, visit
www.vivioninc.com/vivassure.
About Arcadia Biosciences, Inc.
Arcadia Biosciences
(Nasdaq: RKDA) is a leader in science-based approaches to enhancing
the quality and nutritional value of crops and food ingredients.
The company's GoodWheat™ branded ingredients deliver health
benefits to consumers and enable consumer packaged goods companies
to differentiate their brands in the marketplace. Arcadia's agricultural traits are being
developed to enable farmers around the world to be more productive
and minimize the impact of agriculture on the environment. The
company's new GoodHemp seed catalog delivers genetically superior
hemp seeds, clones, transplants, flower and extracts, applying the
company's proprietary crop innovation technology, ArcaTech, to an
emerging crop. For more information, visit
www.arcadiabio.com.
Note Regarding Forward-Looking Statements
This press
release contains forward-looking statements within the meaning of
the Private Securities Litigation Reform Act of 1995, including the expected timing of the products to
market. Forward-looking statements are subject to risks and
uncertainties that could cause actual results to differ materially,
and reported results should not be considered as an indication of
future performance. These risks and uncertainties include, but are
not limited to: Arcadia's and its
partners' and affiliates' expectations about the legal cannabis
industry and potential demand for our products; the uncertainty of
the laws and regulations relating to hemp and products derived
therefrom; the inherent uncertainty associated with the development
of new projects; the acceptance of our products in the marketplace;
the impact of competitive products and pricing; risks related to
costs, delays and uncertainties associated with potential future
scientific research; our future capital requirements and ability to
satisfy our capital needs; ; and the other risks set forth in
Arcadia's filings with the
Securities and Exchange Commission from time to time, including the
risks set forth in Arcadia's
Annual Report on Form 10-K for the year ended December 31, 2018 and other filings. These
forward-looking statements speak only as of the date hereof, and
Arcadia Biosciences, Inc. disclaims any obligation to update these
forward-looking statements.
View original content to download
multimedia:http://www.prnewswire.com/news-releases/arcadia-biosciences-and-archipelago-ventures-announce-strategic-partnership-with-vivion-specialties-inc-to-certify-and-distribute-hawaiian-hemp-products-across-north-america-301027907.html
SOURCE Arcadia Biosciences, Inc.